The Aptima Combo assay is a second-generation nucleic acid amplification test that uses target capture for in vitro qualitative detection and differentiation of rRNA from CT and GC. The assay utilizes the same family of Gen-Probe technologies, including target capture, transcription-mediated amplification, and dual kinetic assays that are used to screen the nation’s blood supply.

Gen-Probe
(800) 523-5001; www.gen-probe.com